Viewing Study NCT01448304


Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2025-12-29 @ 7:06 PM
Study NCT ID: NCT01448304
Status: COMPLETED
Last Update Posted: 2013-06-28
First Post: 2011-10-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of Alirocumab SAR236553 (REGN727)
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module